Docket #: S93-077
A Novel Protein and Gene Expressed by Human T Cells and Monocytes: Alloreaction-Associated Antigen (ARAg)
Alloreaction-associated antigen (ARAg) is a novel member of the immunoglobulin superfamily. This invention's issued US patent claims composition of matter of ARAg polypeptides and nucleic acids encoding ARAg polypeptides.
Stanford research indicates ARAg may serve as an effector of immune response and a diagnostic antigen for antibody-based monitoring of immune disease.
Applications
- Drug Target
- Suppressing immune response using a monoclonal antibody against ARAg
- Monitoring immune diseases using MAb as a diagnostic
- Screening for ARAg receptors
U.S. Patent
U.S. Patent No. 5,646,251
Similar Technologies
-
Mouse Anti-Human Hybridomas: 12E7, L243, L17F12, L368 S79-066Mouse Anti-Human Hybridomas: 12E7, L243, L17F12, L368
-
Novel systems for inhibiting Neuromedin signaling in vivo S15-356Novel systems for inhibiting Neuromedin signaling in vivo
-
A Monoclonal Antibody Specific For Mouse Granulocytes - RB6-8C5 and RA3-6B2 S82-008A Monoclonal Antibody Specific For Mouse Granulocytes - RB6-8C5 and RA3-6B2